Lenacapavir
Patent law changes in Indonesia may hinder access to life-changing medicines
Indonesia’s new patent law has raised alarm over potential barriers to accessing life-saving medicines
London activists push Gilead to lower price of new HIV drug
Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
- Trump’s mass deportation operation escalates with workplace raids
- Jordan bans Muslim Brotherhood, confiscates its assets after alleged security plot
- Medics on hunger strike against Gaza genocide reach European Parliament
- Samidoun Europe coordinator targeted again by Belgian police
- Syria’s interim government arrests senior Palestinian resistance leaders
